Home > Healthcare > Medical Devices > Implantable Devices > Biliary Stents Market

Biliary Stents Market Size

Report ID: GMI4034
Published Date: Dec 2022
Report Format: PDF

Download Free Sample

Biliary Stents Market Size

Biliary Stents Market size surpassed USD 394.5 million in 2022 and is anticipated to record more than 5.5% CAGR between 2023-2032. Technological advancements in detection and treatment of gastrointestinal diseases will augment industry share.

To get key market trends

Download Free Sample

Rising number of patients suffering from gallstones and the growing prevalence of pancreatic and bile duct cancers will increase the use of biliary stents across the world. For instance, according to the American Cancer Society, close to 8,000 people in the U.S. are diagnosed with bile duct cancer (cholangiocarcinoma) annually. Furthermore, the rising adoption of endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures will also boost the demand for biliary stents significantly, thereby augmenting the market expansion.

Technological advancements in the detection and treatment of gastrointestinal diseases, including bile duct obstruction, are leading to several advantages, such as lesser chances of infection, shorter hospital stays, and quicker recovery. Other technological innovations, such as self-expandable metallic stents and bioresorbable stents, enable larger lumen that allows improved patency rate and decreased biofilm formation. Enhanced accuracy levels of ERCP and PTC tests and the burgeoning adoption of minimally invasive surgeries through effective diagnosis procedures are also promoting the usage of biliary stents.

Biliary Stents Market Report Attributes
Report Attribute	Details
Base Year:	2022
Biliary Stents Market Size in 2022:	394.8 Million (USD)
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	5.7%
2032 Value Projection:	699.5 Million (USD)
Historical Data for:	2018 to 2032
No. of Pages:	139
Tables, Charts & Figures:	181
Segments covered:	Product Type, Application, End-use and Region
Growth Drivers:	Increasing prevalence of bile duct and chronic liver disease Technological advancements Adoption of minimally invasive approach to boosts the stents market Growing geriatric population globally
Pitfalls & Challenges:	Complications and risks related to bile duct stents High cost of the plastic bile duct stents

Learn more about the key segments shaping this market

Download Free Sample

However, various risks and complications associated with bile duct stents might hinder the biliary stents market growth. Risk factors such as tumor ingrowth can cause blockage in stents, leading to the buildup of microbial colonies or biofilm formation due to the accumulation of obstructing material. Another severe complication of biliary stenting is the risk of a hole forming in the duodenum during or after the stent placement, which can cause bleeding or infection and create other major problems. These factors may also impede market progress to some extent.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for biliary stents revenue surpassed USD 394.5 million in 2022 and is anticipated to record more than 5.5% CAGR over 2023-2032, due to the rising incidence of bile duct & liver cancers and gastrointestinal diseases.

Polymer biliary stents industry size is expected to register more than 5% CAGR through 2032, due to the widespread demand for hydrophobic materials that are more affordable as compared to their metal counterparts.

Latin America biliary stents market size is projected to depict more than 4.5% CAGR through 2032, given the rapid expansion of the healthcare sector and investments by governments in a wide range of innovative medical technologies.

Boston Scientific, Cook Group, ENDO-FLEX GmbH, Olympus Corporation, B Braun Melsungen, CONMED Corporation, M.I Tech, C.R. Bard (Becton, Dickinson & Company), Medtronic plc, Cardinal Health, and Merit Medical System, are a few of the prominent companies operating in biliary stents business.